NEW YORK, June 14, 2022 /PRNewswire/ -- The active pharmaceutical ingredients (API) market size is expected to grow by USD 64.53 billion from 2020 to 2025, progressing at a CAGR of 6.1% according to the latest market research report by Technavio. 66% of the market's growth will originate from APAC during the forecast period. China, India, and Japan are the key markets for active pharmaceutical ingredients (API) in APAC. Market growth in this region will be faster than the growth of the market in other regions. China accounts for the largest share in the active pharmaceutical ingredients (API) market in APAC. The Chinese pharmaceutical industry mainly produces basic chemicals and APIs. The major reason for China's ability to capture the global active pharmaceutical ingredients (API) market is the cheap and cost-effective production of APIs, resulting from its large-scale manufacturing which will facilitate the active pharmaceutical ingredients (API) market growth in APAC over the forecast period.
For more insights on the market share of various regions - Download a Sample Report
Active Pharmaceutical Ingredients (API) Market: Evolving API manufacturing scenario in developing countries to drive growth
-
The key factor driving the active pharmaceutical ingredients (API) market growth is the evolving API manufacturing scenario in developing countries. Considering the presence of developed infrastructure and growing economic development, India and China have started producing high-quality APIs and drug intermediates for regulated markets.
-
Generic drug manufacturers are keen to work directly with Indian and Chinese API manufacturers as the strategic outsourcing of APIs is necessary for obtaining high-profit margins, while the transfer of intellectual property for preparing APIs is less of a concern than the main monograph for preparing the finished drug products.
-
On average, the manufacturing cost of APIs for generic oral solids, such as tablets and capsules, accounts for approximately 40%-50% of the production cost. In a highly competitive market, where the ability to offer a low price is vital, generic drug manufacturers seek competitive advantages by outsourcing bulk drug manufacturing activities to reliable API manufacturers in developing countries, who can deliver the APIs at a low cost. This is expected to drive the growth of the market during the forecast period.
To know more about other drivers along with the market challenges - Request a Sample Research Report
Active Pharmaceutical Ingredients (API) Market: Segmentation Analysis
The market research report segments the active pharmaceutical ingredients (API) market by Geographic (APAC, North America, Europe, and ROW) and Manufacturing type (captive APIs and contract APIs)
Revenue Generating Segment: The active pharmaceutical ingredients (API) market share growth by the captive APIs will be significant for revenue generation. The increased adoption of healthcare services has benefited the global active pharmaceutical ingredients (API) market significantly. There is a huge focus on increasing the accessibility to affordable healthcare services, and this has led to increased demand for access to low-cost medicines, in turn inducing the demand for low-cost APIs for manufacturing the finished drugs.
To gain further insights into the market contribution of various segments - Download a sample report
Get ready to achieve excellent business outcomes from this exclusive Active Pharmaceutical Ingredients (API) Market report by Technavio. The report will include highlights of the overall market which includes frequently asked questions such as -
-
What are historical revenue figures and estimated revenue figures as well as CAGR during the forecast timeframe?
-
What is the current trend taking place in the market space?|
-
Which are business tactics that will influence competitive scenarios along with defining the growth potential of the market?
-
What are market drivers, restraints, and challenges impacting demand & growth of the market?
-
Which regions & segments will garner massive revenue and emerge as market leaders in upcoming years?
The competitive scenario provided in the Active Pharmaceutical Ingredients (API) Market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc. Don't wait, Make a strategic approach & boost your business goals with our Active Pharmaceutical Ingredients (API) Market Forecast Report - Buy Now!
Related Reports:
-
The pharmaceutical glycerine market share is expected to increase by USD 56.35 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.92%. Download a sample now!
-
The marine pharmaceuticals market size is predicted to surge by USD 1.56 billion from 2021 to 2026 at a CAGR of 7.73%. Download a sample now!
|
Active Pharmaceutical Ingredients (API) Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.1% |
|
Market growth 2021-2025 |
USD 64.53 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
5.80 |
|
Performing market contribution |
APAC at 66% |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Koninklijke DSM NV, Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Content:
1 Executive Summary
2 Market Landscape
-
2.1 Market ecosystem
-
2.3 Value chain analysis
3 Market Sizing
-
3.1 Market definition
-
3.3 Market size 2020
4 Five Forces Analysis
-
4.1 Five forces summary
-
4.6 Threat of rivalry
-
4.7 Market condition
5 Market Segmentation by Manufacturing Type
-
5.1 Market segments
6 Customer landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
-
8.1 Market drivers
-
8.2 Market challenges
-
8.3 Market trends
9 Vendor Landscape
-
9.1 Competitive scenario
-
9.2 Vendor landscape
-
9.3 Landscape disruption
10 Vendor Analysis
-
10.1 Vendors covered
-
10.6 GlaxoSmithKline Plc
-
10.7 Koninklijke DSM NV
-
10.8 Mylan NV
-
10.9 Novartis AG
-
10.10 Pfizer Inc.
11 Appendix
-
11.1 Scope of the report
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/active-pharmaceutical-ingredients-api-market-apac-to-occupy-66-market-sharecaptive-apis-to-be-significant-for-revenue-generation-technavio-301566559.html
SOURCE Technavio
"ingredients" - Google News
June 14, 2022 at 02:30PM
https://ift.tt/I8N90Gl
Active Pharmaceutical Ingredients (API) Market: APAC to Occupy 66% Market Share|Captive APIs to be Significant for Revenue Generation |Technavio - Yahoo Finance
"ingredients" - Google News
https://ift.tt/8ts2huO
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Active Pharmaceutical Ingredients (API) Market: APAC to Occupy 66% Market Share|Captive APIs to be Significant for Revenue Generation |Technavio - Yahoo Finance"
Post a Comment